ப்ரோடொகால் விமர்சனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ரோடொகால் விமர்சனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ரோடொகால் விமர்சனம் Today - Breaking & Trending Today

A Cold War Deal on Ice: The Antarctic Treaty at 60

A Cold War Deal on Ice: The Antarctic Treaty at 60
realcleardefense.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from realcleardefense.com Daily Mail and Mail on Sunday newspapers.

United States , Arctic Ocean , United Kingdom , South Africa , Australian Capital Territory , New Zealand , Donaldr Rothwell , Daniel Enchev Flickr , Tim Stephens , Seals Convention , International Law , Union Of Soviet Socialist Republics Russia , International Law Of The Sea , Marine Living Resources Convention , Arctic Council , Un Security Council , Old Parliament House , Antarctic Treaty , Parliament House , Soviet Socialist Republics , Antarctic Treaty System , Living Resources Convention , Madrid Protocol , Southern Ocean , Treaty Consultative Meeting , Protocol Review ,

Lupus Research Alliance Hails Approval of Aurinia's Lupkynis(TM) (voclosporin)

Lupus Research Alliance Hails Approval of Aurinia s Lupkynis(TM) (voclosporin)
First Oral Treatment for Lupus Nephritis;
Second Lupus Treatment to Receive FDA Approval in Past Month
News provided by
Share this article
Share this article
NEW YORK, Jan. 22, 2021 /PRNewswire/ The Lupus Research Alliance (LRA) is excited to share that the U.S. Food and Drug Administration (FDA) approved the use of Aurinia Pharmaceuticals Lupkynis
TM (voclosporin) as the first oral treatment developed specifically for adults with active lupus nephritis (LN) in combination with standard of care. Voclosporin follows the recent approval of belimumab by the FDA as new therapies indicated for lupus nephritis – both within the past month. ....

United States , Brad Rovin , Kennethm Farber , Lupus Research Alliance Board Of Directors , National Institute Of Diabetes , Lupus Research Alliance , Aurinia Pharmaceuticals Inc , Ohio State University , Drug Administration , Division Of Nephrology , Clinical Research Management , National Institutes Of Health Accelerating Medicines Partnership , National Kidney Foundation , Aurinia Pharmaceuticals , Wexner Medical Center , Aurinia Pharmaceutical , National Kidney , Research Alliance President , Medical Director , Wexner Medical , Protocol Review , Design Sub Committee , Lupus Clinical Investigators Network , Lupus Therapeutics , Lupus Research , National Institutes ,

A conversation with a Rigvir flack

By oracknows
on October 8, 2017.
Over the last two Mondays, I ve been writing about an unproven cancer therapy that I hadn t really heard much about before. The cancer treatment is called Rigvir; it is manufactured in Latvia and marketed primarily through a Latvian entity called the International Virotherapy Center (IVC).
To recap, Rigvir is an unmodified Echovirus, specifically ECHO-7, that, according to the IVC, seeks out cancer cells, replicates in them, and thus lyses the cancer cells (causes their membranes to break, spilling out the cancer cells contents, thus killing the cell), hence the term oncolytic virus.
Somehow, mysteriously Rigvir was approved by the Latvian equivalent of the FDA in 2004 for the treatment of malignant melanoma despite what appears to have been grossly inadequate supporting evidence and then even more mysteriously placed on the Latvian Health Ministry s list of reimbursable medications in 2011. I suspect that the rea ....

United States , Republic Of Latvia , Ivars Kalvins , Eduards Ritum , Kaspars Losans , Mike Adams , Inara Rubene , Lelde Lapa , Peteris Alberts , Eduards Ritums , Antonio Jimenez , Lelde Lapa Assistant Of Business Development Department , Rigvir Holding , Development Department Orac , International Virotherapy Center , Virotherapy Institute , Virotherapy Center , Development Department Dear Orac , Monitoring Committee , International Virology Center , Drug Administration , Latvian Doctors Congress , Cancer Institute , Melanoma Research , Business Development Department , Latvian Health Ministry ,